A highly stimulating programme on pharmaceutical R&D and BD&L in the form of a boardgame called Risky Business.
Read more…
Courses for R&D portfolio managers and R&D project leaders and teams to improve strategic decision making.
Read more…
Team TrainingWe have developed unique training courses specifically designed for the needs of pharmaceutical R&D project teams.
Read more…
We tailor existing courses on strategy and decision analysis or create new courses for specific training needs.
Read more…
"I have worked with Catenion on several occasions — from an in–depth assessment of our ethical pipeline, to health–economic analyses, to a customised training for my executive team by The Catenion Academy. The Catenion team always focused on our specific needs as a family–owned business while providing the perspective of large pharmaceutical corporations. Their insights had great impact on our internal discussions and development."
M. Germano Giuliani
President & CEO
Giuliani S.p.A.
Expert Partner in BD&L
England
Email: gavin.d.clark@catenion.com
Gavin D. Clark is an Expert Partner in BD&L with Catenion and lives in England.
Gavin is a native Scot and a graduate Chemist (University of Strathclyde) with 30 years of experience in the industry including commercial positions at Janssen Pharmaceutica, Bayer and Novartis. More recently he was responsible for Global Infectious Diseases Licensing at GlaxoWellcome and VP Business Development at Tibotec Pharmaceuticals. In the former role he closed 8 deals including those with Otsuka, Paratek, and Pliva and was responsible for business development at Tibotec until the acquisition by Johnson & Johnson in 2002. Since then Gavin has consulted in commercial roles via his consulting company in the UK, Marlin Bioconsulting Ltd, and has worked on a number of fundraising, M&A and Licensing deals for his client base in the US, Asia Pacific and the EU.
He is a Certified Licensing Professional (CLP) as accredited by the Licensing Executives Society North America; a former member of the training faculty at the UK Pharmaceutical Licensing Group, this year Gavin created and led an Advanced Licensing course "Technology Transfer in the Biopharma Sector" for Pharma Business Brazil in São Paulo. He serves as Non–Executive Director at Edinburgh based Angel Biotechnology Holdings plc.
Gavin is a passionate sailor, spending as much time as he can racing performance dinghies on the UK south coast and chartering cruising yachts when time permits.